Benedict Barnes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benedict Barnes has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Anders Dalsgaard
Food Safety and Zoonoses, Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Stigböjlen 4, 1870 Frederiksberg C, Denmark
1 shared publicationAnders Permin
Office for Innovation and Sector Services, Administration, Technical University of Denmark, Anker Engelunds Vej, 2800 Kgs Lyngby, Denmark
1 shared publication- Emmanuel De-Graft Johnson Owusu-Ansah
Department of Mathematics, College of Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
1 shared publication Robert Abaidoo
Department of Theoretical and Applied Biology, Faculty of Bio Science, College of Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
1 shared publication- Tine Hald
National Food Institute, Technical University of Denmark, 2800 Kongens Lyngby, Denmark
1 shared publication Torben Wilde Schou
Environment and Toxicology, DHI, Horsholm, Denmark
1 shared publication
Latest Publications
- Open Access
- 1 January 2019
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 4, 99-114
Probabilistic modeling for an integrated temporary acquired immunity with norovirus epidemiological data
Integration of acquired immunity into microbial risk assessment for illness incidence is of no doubt essential for the study of susceptibility to illness. In this study, a probabilistic model was set up as dose response for infection and a mathematical derivation was carried out by integrating immunity to obtain probability of illness models. Temporary acquire immunity from epidemiology studies which includes six different Norovirus transmission scenarios such as symptomatic individuals infectious, pre- and post-symptomatic infectiousness (low and high), innate genetic resistance, genogroup 2 type 4 and those with no immune boosting by asymptomatic infection were evaluated. Simulated results on illness inflation factor as a function of dose and exposure indicated that high frequency exposures had immense immunity build up even at high dose levels; hence minimized the probability of illness. Using Norovirus transmission dynamics data, results showed, and immunity included models had a reduction of 2-6 logs of magnitude difference in disease burden for both population and individual probable illness incidence. Additionally, the magnitude order of illness for each dose response remained largely the same for all transmission scenarios; symptomatic infectiousness and no immune boosting after asymptomatic infectiousness also remained the same throughout. With integration of epidemiological data on acquired immunity into the risk assessment, more realistic results were achieved signifying an overestimation of probable risk of illness when epidemiological immunity data are not included. This finding supported the call for rigorous integration of temporary acquired immunity in dose-response in all microbial risk assessments.
- 1 January 2019
- Published by KEAI Publishing in Infectious Disease Modelling
- Vol. 4, 99-114
Open AccessProbabilistic modeling for an integrated temporary acquired immunity with norovirus epidemiological data
Integration of acquired immunity into microbial risk assessment for illness incidence is of no doubt essential for the study of susceptibility to illness. In this study, a probabilistic model was set up as dose response for infection and a mathematical derivation was carried out by integrating immunity to obtain probability of illness models. Temporary acquire immunity from epidemiology studies which includes six different Norovirus transmission scenarios such as symptomatic individuals infectious, pre- and post-symptomatic infectiousness (low and high), innate genetic resistance, genogroup 2 type 4 and those with no immune boosting by asymptomatic infection were evaluated. Simulated results on illness inflation factor as a function of dose and exposure indicated that high frequency exposures had immense immunity build up even at high dose levels; hence minimized the probability of illness. Using Norovirus transmission dynamics data, results showed, and immunity included models had a reduction of 2-6 logs of magnitude difference in disease burden for both population and individual probable illness incidence. Additionally, the magnitude order of illness for each dose response remained largely the same for all transmission scenarios; symptomatic infectiousness and no immune boosting after asymptomatic infectiousness also remained the same throughout. With integration of epidemiological data on acquired immunity into the risk assessment, more realistic results were achieved signifying an overestimation of probable risk of illness when epidemiological immunity data are not included. This finding supported the call for rigorous integration of temporary acquired immunity in dose-response in all microbial risk assessments.